Diagnosis of mycobacterial lymphadenopathy.

D. Burgner,A. Kakakios
DOI: https://doi.org/10.1136/adc.73.3.276-c
1995-09-01
Archives of Disease in Childhood
Abstract:The effect of immunoglobulin on VP repertoire is uncertain. Therefore the demonstration ofVP changes after administration of immunoglobulin early in the disease may be difficult. In the UK, Kawasaki disease is unfortunately still often diagnosed late outside paediatric centres, and treatment with immunoglobulin may therefore be delayed beyond the tenth day of illness. This has enabled us to study patients referred up to 21 days after disease onset before the administration of immunoglobulin. In contrast to Leung et al we have found a variety of different staphylococcal toxins in throat and nose swab culture supematants from patients with Kawasaki disease and their relatives.2 In addition we have found activity suggesting the presence of one or more novel superantigen toxin or toxins. We propose that Kawasaki disease is either caused by more than one toxin or is caused by a novel superantigen toxin. We disagree that we may have misled readers to conclude that superantigen involvement in Kawasaki disease is a proved fact. We concluded that our data 'supports the hypothesis that a superantigen is involved in the pathogenesis of Kawasaki disease'; a hypothesis that remains to be tested in further studies.
What problem does this paper attempt to address?